Skip to Content

  • Search

View Additional Section Content

CC-5013-CLL-002 – A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupStudy of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for Patients with B-Cell Chronic Lymphocytic Leukemia Following Second-Line Therapy (The Continuum Trial).

Principal Investigator(s)
Peter V. Pickens, M.D.
Robert A. Maxwell, M.D. (Sub-Investigator)
Joseph L. Potz, M.D. (Sub-Investigator)
Marc J. Chernoff, D.O. (Sub-Investigator)
Vishwanath Gharpure, M.D. (Sub-Investigator)
Jason A. Damsker, M.D. (Sub-Investigator)
Felice LePar, M.D. (Sub-Investigator)
Pallav Mehta, M.D. (Sub-Investigator)
Michael J. Seidman, M.D. (Sub-Investigator)
Jessica A. Berman, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Leukemia
Contact
Diane Foley, CCRP at 215-692-3213

Location

  • Abington Hematology/Oncology Associates
    Abington Health Center - Schilling
    2510 Maryland Rd, Ste 175
    Willow Grove, PA 19090-1108
    Office: 215-706-2034
    Fax: 215-706-4176

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details